Basis of Presentation and Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Schedule of Disaggregated Revenue by Each Payor Type

The following table presents disaggregated revenue generated by payor type for the three months ended March 31, 2021 and 2020 (in thousands):

	Three Months Ended March 31,
	2021		2020
Commercial	$	32,266	$	24,710
Medicare	64,677		68,641
Medicaid	69,664		62,690
Other third parties	9,451		9,064
Revenue	$	176,058	$	165,105

Schedule of Contributions to Revenue and Receivables by Payor

The Company had major payors that contributed the following percentages of net revenue:

	Three Months Ended March 31,
	2021		2020
Payor A	12.8	%	12.1	%
Payor B	10.5	%	10.3	%
Payor C	16.9	%	17.6	%
Payor D	*		13.3	%

*    Less than 10% of total net revenues

The Company had major payors that contributed to the following percentages of receivables and receivables – related parties:

	As of March 31, 2021		As of December 31, 2020
Payor C	11.9	%	*
Payor E	42.8	%	43.9	%
Payor F	32.3	%	36.5	%

*    Less than 10% of total receivables and receivables — related parties, net

Schedule of Carrying Amounts and Fair Values of Financial Instruments

The carrying amounts and fair values of the Company’s financial instruments as of March 31, 2021, are presented below (in thousands):

	Fair Value Measurements
	Level 1		Level 2		Level 3		Total
Assets
Money market funds*	$	126,985	$	—	$	—	$	126,985
Marketable securities – certificates of deposit	66,862		—		—		66,862
Marketable securities – equity securities	69		—		—		69
Total	$	193,916	$	—	$	—	$	193,916

The carrying amounts and fair values of the Company’s financial instruments as of December 31, 2020, are presented below (in thousands):

	Fair Value Measurements
	Level 1		Level 2		Level 3		Total
Assets
Money market funds*	$	115,769	$	—	$	—	$	115,769
Marketable securities – certificates of deposit	67,637		—		—		67,637
Marketable securities – equity securities	58		—		—		58
Total	$	183,464	$	—	$	—	$	183,464

*    Included in cash and cash equivalents